OPTO-BLUE: An Integrated Bidirectional Optogenetic Lentiviral Platform for Controlled Light-Induced Gene Expression.
GAVPO
bidirectional
gene-regulated expression
lentivirus
optogenetic
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
31 May 2023
31 May 2023
Historique:
received:
01
05
2023
revised:
27
05
2023
accepted:
30
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Regulated systems for transgene expression are useful tools in basic research and a promising platform in biomedicine due to their regulated transgene expression by an inducer. The emergence of optogenetics expression systems enabled the construction of light-switchable systems, enhancing the spatial and temporal resolution of a transgene. The LightOn system is an optogenetic tool that regulates the expression of a gene of interest using blue light as an inducer. This system is based on a photosensitive protein (GAVPO), which dimerizes and binds to the UASG sequence in response to blue light, triggering the expression of a downstream transgene. Previously, we adapted the LightOn system to a dual lentiviral vector system for neurons. Here, we continue the optimization and assemble all components of the LightOn system into a single lentiviral plasmid, the OPTO-BLUE system. For functional validation, we used enhanced green fluorescent protein (EGFP) as an expression reporter (OPTO-BLUE-EGFP) and evaluated the efficiency of EGFP expression by transfection and transduction in HEK293-T cells exposed to continuous blue-light illumination. Altogether, these results prove that the optimized OPTO-BLUE system allows the light-controlled expression of a reporter protein according to a specific time and light intensity. Likewise, this system should provide an important molecular tool to modulate gene expression of any protein by blue light.
Identifiants
pubmed: 37298488
pii: ijms24119537
doi: 10.3390/ijms24119537
pmc: PMC10253389
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agencia Nacional de Investigación y Desarrollo
ID : VIU20P0060
Organisme : Universidad de Antofagasta
ID : SEM 18-4
Références
Mol Ther Methods Clin Dev. 2021 Apr 16;21:574-584
pubmed: 34095341
ACS Synth Biol. 2023 Mar 17;12(3):664-671
pubmed: 36891673
Curr Opin Biotechnol. 1997 Oct;8(5):608-16
pubmed: 9353233
Nucleic Acids Res. 2020 Apr 6;48(6):e33
pubmed: 31989175
Science. 2002 Feb 1;295(5556):868-72
pubmed: 11786607
Biochemistry. 2008 Jul 8;47(27):7012-9
pubmed: 18553928
Curr Protoc Chem Biol. 2013;5(2):111-29
pubmed: 23839993
BMC Biotechnol. 2021 Feb 4;21(1):13
pubmed: 33541329
Nat Methods. 2012 Feb 12;9(3):266-9
pubmed: 22327833
Acta Pharm Sin B. 2020 Sep;10(9):1741-1753
pubmed: 33088693
Science. 2013 Dec 6;342(6163):1203-8
pubmed: 24179156
Gene Ther. 2017 May;24(5):298-307
pubmed: 28346436
Curr Opin Biotechnol. 2009 Aug;20(4):449-60
pubmed: 19762224
PLoS One. 2018 Jul 20;13(7):e0201028
pubmed: 30028876
Nucleic Acids Res. 2013 Apr;41(7):e77
pubmed: 23355611
Biochem Biophys Res Commun. 2015 Oct 2;465(4):769-76
pubmed: 26301633
Appl Microbiol Biotechnol. 2018 May;102(9):3849-3863
pubmed: 29569180
Biochem Biophys Res Commun. 2013 Oct 25;440(3):419-23
pubmed: 24095689
Appl Microbiol Biotechnol. 2017 Apr;101(7):2629-2640
pubmed: 28210796
Biochem J. 2012 May 1;443(3):603-18
pubmed: 22507128
Methods Mol Biol. 2016;1382:107-14
pubmed: 26611582
Dev Growth Differ. 2021 Apr;63(3):189-198
pubmed: 33733477
Nat Methods. 2011 Jan;8(1):35-8
pubmed: 21191370
J Biol Chem. 2010 Apr 9;285(15):11033-8
pubmed: 20147748
Development. 2020 Jun 17;147(12):
pubmed: 32414936
Adv Exp Med Biol. 2021;1293:235-246
pubmed: 33398817
Mol Ther. 2005 Aug;12(2):189-211
pubmed: 15946903
Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt A):1579-1589
pubmed: 30327199
Nat Commun. 2021 Jan 27;12(1):615
pubmed: 33504786
Cells. 2019 Jul 30;8(8):
pubmed: 31366153